Carregant...
Re-introducing the same chemotherapy after exposure to anti-PD-1 therapy
Cytotoxic chemotherapy after exposure to nivolumab (nivo), an anti-programmed death-1 (PD-1) antibody, has been associated with good response compared with historical data in various cancers including head and neck squamous cell carcinoma (HNSCC). In a previous report, different chemotherapy regimen...
Guardat en:
| Publicat a: | Int Cancer Conf J |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer Singapore
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6498283/ https://ncbi.nlm.nih.gov/pubmed/31149554 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13691-019-00360-y |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|